Multidisciplinary Evaluation denied as duplicate or overlapping therapy by Humana?

Humana's specific coverage criteria for multidisciplinary evaluation are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denies a Multidisciplinary Evaluation as Duplicate Therapy — and How to Appeal

A 'duplicate therapy' denial on a multidisciplinary evaluation typically means Humana's claims system identified a recent evaluation or assessment of a similar type and concluded a second evaluation is redundant. This denial type is particularly ill-suited to multidisciplinary evaluations, which by definition involve multiple distinct clinical disciplines (e.g., medicine, psychology, social work, rehabilitation, or specialty-specific panels) and serve a purpose that cannot be replicated by a single-specialty visit.

## Why This Denial Is Appealable

A multidisciplinary evaluation is a distinct service — it produces an integrated, cross-disciplinary clinical picture that no single prior visit duplicates. If Humana's denial is based on a code-matching algorithm that flagged a recent single-specialty visit, that is a factual error in the review process. Your appeal should demonstrate, using chart documentation, that the prior service(s) Humana identified do not constitute the same clinical service as the requested evaluation.

## Your Federal Appeal Rights

• Internal appeal (ERISA §503 / ACA §2719): You have the right to a full-and-fair internal review. Request the specific prior service(s) Humana identified as duplicative, and the clinical criteria used to make that determination.
• External review (ACA §2719): If the internal appeal is denied, request IRO review within approximately four months of the original denial. Expedited review is available when delay creates serious health risk.

## Appeal Timeline

1. Request Humana's denial rationale in writing, including the specific claim(s) identified as duplicating the requested service. 2. Obtain the clinical records for those prior services to demonstrate their scope differs from the requested multidisciplinary evaluation. 3. Submit the internal appeal with the documentation below. 4. If denied, file for external IRO review within the statutory window.

## Documentation to Gather

• Service description: A clear written description from the referring or ordering provider of what the multidisciplinary evaluation entails and which disciplines will be involved.
• Differentiation from prior services: A side-by-side comparison showing that the prior services Humana flagged did not include the same disciplines or produce the same integrated assessment.
• Clinical necessity letter: A letter from the ordering provider explaining why an integrated multidisciplinary evaluation is needed now, referencing new clinical developments or the inadequacy of prior single-specialty assessments.
• Relevant guideline reference: Reference to the applicable specialty guideline organization that recommends multidisciplinary evaluation for the patient's condition.

## Criteria-Mapping Structure

Request Humana's duplicate-therapy criteria in writing. For each stated basis for duplication, cite the specific chart evidence showing the prior service was materially different in scope, disciplines, or purpose. Submit this mapping as a numbered exhibit alongside the ordering provider's letter.